TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 46 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $45,000 | -69.4% | 49,000 | -64.2% | 0.00% | -100.0% |
| Q1 2017 | $147,000 | -83.7% | 137,000 | -80.6% | 0.00% | -83.3% |
| Q3 2014 | $904,000 | +0.4% | 705,000 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $900,000 | +0.7% | 705,000 | 0.0% | 0.01% | +100.0% |
| Q1 2014 | $894,000 | +0.3% | 705,000 | -16.1% | 0.00% | 0.0% |
| Q4 2013 | $891,000 | +2.4% | 840,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $870,000 | -1.0% | 840,000 | 0.0% | 0.00% | -25.0% |
| Q2 2013 | $879,000 | – | 840,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 95,823,000 | $114,365,000 | 5.28% |
| INCOME RESEARCH & MANAGEMENT | 12,056,000 | $14,384,000 | 2.34% |
| AEGON USA Investment Management, LLC | 6,000,000 | $7,159,000 | 1.44% |
| MACKAY SHIELDS LLC | 18,832,000 | $22,547,000 | 1.02% |
| CSS LLC/IL | 14,850,000 | $17,728,000 | 0.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,492,000 | $10,174,000 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,022,000 | $39,393,000 | 0.57% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,088,000 | $7,254,000 | 0.26% |
| AXA S.A. | 34,000,000 | $40,566,000 | 0.18% |
| SSI INVESTMENT MANAGEMENT LLC | 1,664,000 | $1,975,000 | 0.18% |